论文部分内容阅读
近日,发表于国际杂志Nature Communications上的一项研究论文中,来自诺丁汉大学、乌普萨拉大学及GE Healthcare的研究人员通过研究开发了一种制造人类干细胞的新方法,该方法或可解决目前大规模生产干细胞的需求,从而为深入理解并且研究开发治疗疾病的新型疗法或将提供新希望。人类多能干细胞和未分化的细胞具有潜力分化为机体所有不同类型的细胞,干细胞在疾病模型、药物筛选、再生医学及组织功能领域有着巨大的应用。目前,科学家们对干细胞的需求量巨大,未来在临床上及制药工业中的使用量将会持续增加。在现代医药体系中当前这种进行优化应用的干细胞的产生或
Recently, in a research paper published in the journal Nature Communications, researchers from the University of Nottingham, University of Uppsala, and GE Healthcare developed a novel method of making human stem cells that could solve the current Large-scale production of stem cells needs, so as to understand and research and development of new therapies for the treatment of new diseases or will provide new hope. Human pluripotent stem cells and undifferentiated cells have the potential to differentiate into all the different types of cells in the body. Stem cells are of great use in disease models, drug screening, regenerative medicine and tissue function. At present, scientists are in great need of stem cells and will continue to increase their use in the clinic and in the pharmaceutical industry in the future. The current generation of stem cells for optimal use in modern pharmaceutical systems